Bashford-Rogers, R. J. M.
Bergamaschi, L.
McKinney, E. F.
Pombal, D. C.
Mescia, F.
Lee, J. C.
Thomas, D. C.
Flint, S. M.
Kellam, P.
Jayne, D. R. W.
Lyons, P. A.
Smith, K. G. C.
Article History
Received: 20 December 2018
Accepted: 21 August 2019
First Online: 25 September 2019
Competing interests
: R.J.M.B.-R., P.K. and K.G.C.S. are all named on a patent associated with the methodologies in this paper. S.M.F. is a current employee of GlaxoSmithKline, and holds shares in GlaxoSmithKline. R.J.M.B.-R. is a consultant for Imperial College London and VHSquared. P.K. is an employee and holder of shares in Kymab Ltd. D.R.W.J. is a recipient of a research grant from Roche and Genentech. K.G.C.S. is a co-founder of Rheos Medicines and K.G.C.S., P.A.L. and E.F.M. are co-founders of PredictImmune.